7 studies found for:    "Stargardt macular degeneration" [DISEASE] OR NCT00254605 [ID-NUMBER] OR NCT01278277 [ID-NUMBER] OR NCT00060749 [ID-NUMBER] OR NCT00346853 [ID-NUMBER] OR NCT00420602 [ID-NUMBER]
Show Display Options
RSS Create an RSS feed from your search for:
"Stargardt macular degeneration" [DISEASE] OR NCT00254605 [ID-NUMBER] OR NCT01278277 [ID-NUMBER] OR NCT00060749 [ID-NUMBER] OR NCT00346853 [ID-NUMBER] OR NCT00420602 [ID-NUMBER]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  DHA Supplementation in Patients With STGD3
Condition: Dominantly Inherited Stargardt's Disease (STGD3)
Intervention: Dietary Supplement: Over the counter DHA/EPA dietary supplementation
2 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
3 Completed Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-Like Macular Dystrophy
Condition: Macular Degeneration
Intervention: Drug: Docosahexaenoic Acid (DHA) Dietary Supplement
4 Completed Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
Condition: Macular Dystrophy, Corneal
Interventions: Drug: 4-Methylpyrazole;   Other: saline
5 Recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
6 Recruiting Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration
Condition: Stargardt Disease
Intervention: Genetic: StarGen
7 Enrolling by invitation A Study to Determine the Long Term Safety, Tolerability and Biological Activity of StarGen™ in Patients With Stargardt's Macular Degeneration
Condition: Stargardt Disease
Intervention: Drug: StarGen

Indicates status has not been verified in more than two years